Seer (NASDAQ:SEER) Shares Down 2.7%

Seer, Inc. (NASDAQ:SEER)’s stock price traded down 2.7% during mid-day trading on Monday . The company traded as low as $1.77 and last traded at $1.79. 1,043,092 shares traded hands during mid-day trading, an increase of 131% from the average session volume of 451,460 shares. The stock had previously closed at $1.84.

Analyst Ratings Changes

Separately, Morgan Stanley reissued an “equal weight” rating and issued a $7.00 target price on shares of Seer in a research report on Tuesday, March 5th.

Seer Stock Down 3.4 %

The stock has a 50-day simple moving average of $1.81 and a 200-day simple moving average of $1.79. The firm has a market capitalization of $109.47 million, a PE ratio of -1.25 and a beta of 1.65.

Seer (NASDAQ:SEER) last released its earnings results on Thursday, February 29th. The company reported ($0.28) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.07. The business had revenue of $4.44 million during the quarter, compared to the consensus estimate of $4.24 million. Seer had a negative return on equity of 20.87% and a negative net margin of 517.84%. Equities analysts forecast that Seer, Inc. will post -1.22 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Omid Farokhzad sold 52,857 shares of Seer stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $2.03, for a total value of $107,299.71. Following the completion of the transaction, the chief executive officer now directly owns 1,436,285 shares in the company, valued at $2,915,658.55. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Over the last three months, insiders sold 69,149 shares of company stock worth $133,366. 15.02% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Seer

Several hedge funds have recently made changes to their positions in the stock. BlackRock Inc. increased its holdings in Seer by 7.7% during the 2nd quarter. BlackRock Inc. now owns 5,277,717 shares of the company’s stock valued at $22,536,000 after purchasing an additional 375,715 shares during the period. Softbank Group CORP. purchased a new position in Seer during the 1st quarter valued at about $19,823,000. Vanguard Group Inc. increased its holdings in Seer by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 4,427,188 shares of the company’s stock valued at $34,267,000 after purchasing an additional 37,054 shares during the period. T. Rowe Price Investment Management Inc. increased its holdings in Seer by 10.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,235,771 shares of the company’s stock valued at $12,968,000 after purchasing an additional 204,284 shares during the period. Finally, Capital World Investors increased its holdings in Seer by 58.4% during the 1st quarter. Capital World Investors now owns 2,170,000 shares of the company’s stock valued at $33,071,000 after purchasing an additional 800,000 shares during the period. 75.20% of the stock is currently owned by hedge funds and other institutional investors.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.